Subscribe
susan-montgomery-shutterstock-com-lilly-logo-
Susan Montgomery / Shutterstock.com
15 February 2016Big Pharma

Eli Lilly loses latest round of Alimta patent battle

Eli Lilly has lost the latest round of its patent battle with Allergan centring on the lung cancer drug Alimta (pemetrexed disodium).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Eli Lilly wins Alimta appeal at English Court of Appeal
29 June 2015   The English Court of Appeal has ruled in favour of Eli Lilly, finding that a patent covering its blockbuster lung drug Alimta would be infringed by a product proposed by Actavis, now Allergan.
Big Pharma
UK Supreme Court to hear Alimta patent dispute
24 March 2016   The UK Supreme Court has said it will hear a patent dispute between Eli Lilly and Allergan centring on cancer drug Alimta.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Americas
Eli Lilly wins Alimta appeal at English Court of Appeal
29 June 2015   The English Court of Appeal has ruled in favour of Eli Lilly, finding that a patent covering its blockbuster lung drug Alimta would be infringed by a product proposed by Actavis, now Allergan.
Big Pharma
UK Supreme Court to hear Alimta patent dispute
24 March 2016   The UK Supreme Court has said it will hear a patent dispute between Eli Lilly and Allergan centring on cancer drug Alimta.

More on this story

Americas
Eli Lilly wins Alimta appeal at English Court of Appeal
29 June 2015   The English Court of Appeal has ruled in favour of Eli Lilly, finding that a patent covering its blockbuster lung drug Alimta would be infringed by a product proposed by Actavis, now Allergan.
Big Pharma
UK Supreme Court to hear Alimta patent dispute
24 March 2016   The UK Supreme Court has said it will hear a patent dispute between Eli Lilly and Allergan centring on cancer drug Alimta.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility